Draw a card. If you have Plusle in play, draw 2 cards instead.
During your opponent's next turn, any damage done by attacks from the Defending Pokémon is reduced by 10 (before applying Weakness and Resistance).
Choose 1 of your opponent's Pokémon that has any Poké-Powers. This attack does 30 damage to that Pokémon. (Don't apply Weakness and Resistance for Benched Pokémon.)
Release year for POP Series 3 is 2006. POP Series 3 is grouped under the POP era.
The checklist contains 17 cards, placing it in a compact expansion range. As of 2026, the set is 20 years old and fits a legacy-era profile.
Within this set, Minun is card number 4 with a Rare designation.
Minun is a POP Series 3 card from the 2006 release window. Its card type is Pokémon.
The rarity label is Rare. Printed HP is 50.
Energy typing is Lightning. This gives collectors a clear identity footprint for the print.
This print is categorized under the Basic subtype. Attack line includes "Cheer Up", "Negative Ion", and "Power Bolt".
For Minun in POP Series 3, the current reference price is $5.78. Price action is stable over 7 days, moving only 0.0%.
Current pricing is broadly aligned with its 30-day average ($5.78). The 90-day observed range is flat at $5.78, signaling very low variability.
The listed rarity for this print is Rare.
Minun sits within a broader pool of Minun variants that can be compared by set, rarity, and price. The current sample spans 6 comparable cards from 5 sets.
In this sample, pricing ranges between $0.13 and $38.10 (29208% total span). Relative to the alternative average ($8.26), this card is -30%.
Notable alternatives include Minun #32 (Furious Fists) at $0.41, Minun #6 (EX Trainer Kit 2 Minun) at $10.12, Minun #90 (Fusion Strike) at $0.18, and Minun #194 (Paradox Rift) at $38.10.
Pricing context for collectors: Short-term movement is stable (0.0% over 7 days), with price action clustered near recent averages. The 90-day range spans $5.78 to $5.78 (0% spread), which indicates low-volatility behavior.
Relative to the 30-day baseline ($5.78), pricing is near equilibrium. Graded context points to a substantial premium curve, with PSA 10 at +17616% above raw pricing.
PSA 9 is currently around $28.00, while PSA 10 is $1024.00.
